The present invention relates to a protective release sheet for a microneedle patch.
As a method of administering a drug to a human body, an oral administration method and a transdermal administration method are used. Injection is a typical transdermal administration method, but it is painful and likely to cause an infection so that it is not a procedure to be welcome. In contrast, a transdermal administration method without pain using a microneedle array has been recently attracting attention (Patent Document 1, Non-patent Document 1).
Stratum corneum works as a barrier to drug permeation so that only applying a drug on a skin surface cannot cause enough permeability. In contrast, perforation of corneum by using a minute needle, i.e. a microneedle can remarkably improve efficiency in drug permeability compared to that in the application method. It is a microneedle array in which a large number of the microneedles are integrated on a substrate. In addition, a product in which sheets such as an adhesive tape for adhering the microneedle array to a skin or a protective release sheet for protecting and supporting the adhesive tape when applying the microneedle array to a skin are added to the microneedle array in order to facilitate its use is called a microneedle patch. Herein, an adhesive tape means a film, a fabric or a paper to which an adhesive agent is applied.
When a microneedle is produced by using a substance such as a saccharide which dissolves in a body and disappears by metabolism as a material, an accident is not caused even if the needle is broken and remains in a skin. Furthermore, if a drug is contained in the saccharide, the drug can be easily administered into and under the skin by dissolving the inserted microneedle in the body (Patent Document 2).
The protective release sheet is applied on an adhesive face of the microneedle patch. In insertion of the microneedle, a back of the adhesive tape (a face without adhesive agent) and the protective release sheet are pinched by fingers, and the protective release sheet is peeled off so as to apply the microneedle patch on a skin. The microneedle should not be brought into contact with the fingers during the removal of the protective release sheet.
For the conventional transdermal patch without microneedle, the protective release sheet is usually attached to the whole surface of the adhesive agent. In this process, cutting lines are provided on the protective release sheet, the protective release sheet is hold by a hand, is convexly bent outward and is peeled off so as to apply the transdermal patch on the skin. However, in the case of the conventional microneedle patch, the substrate of the microneedle array was so hard that the patch could not be convexly bent outward, and therefore the patch could not be bent so as to remove the protective release sheet.
[Non-Patent Document 1] Quan Ying-Shu, Kamiyama Fumio, The Course of Development and Manufacturing for Microneedle, Yakuzaigaku; The Academy of Pharmaceutical Science and Technology. Japan; H21-July 69(4), 272-276.
Recently, a microneedle array having a flexible substrate has been developed, and ideas for facilitating application of a microneedle patch thereof on a skin have been required. For applying the microneedle patch having the flexible substrate on the skin, a protective release sheet and the back of an adhesive tape are pinched by fingers, and the protective release sheet is removed from the microneedle patch to apply the patch on the skin. In this step, there is a risk of contamination of the microneedle by bringing the fingers into contact with the adhesive face and the microneedle when removing the protective release sheet.
The protective release sheet of the microneedle patch according to the present invention made for solving the above-mentioned problem is characterized by comprising a hole inside and one or more cutting lines running from an outer edge of the protective release sheet to the hole.
The protective release sheet comprises the hole because it is unfavorable that the microneedles is covered by the protective release sheet, and the microneedle patch requires cares different from those required for conventional transdermal patches without microneedles. Preferably, the size of the hole on the protective release sheet is larger than the microneedle patch for preventing damage of the needles of the microneedle patch, and the microneedle array is completely put into the hole.
Since the protective release sheet is placed on the adhesive tape, the hole thereof is preferably smaller than the adhesive tape and the protective release sheet covers the peripheral part of the adhesive tape.
The hole on the protective release sheet can be formed somewhat larger than the microneedle array. There is only the adhesive tape in the interspace between the protective release sheet and the microneedle array, and the width of the interspace is preferably 0.3-3 mm. The presence of the interspace can prevent damage of the microneedle array when removing the protective release sheet. If this interspace is smaller than 0.3 mm, the above-mentioned effect can hardly be achieved, and if it is larger than 3 mm, the adhesive tape is bent when the protective release sheet is to be held in a container, and the microneedle array hangs down, resulting in a risk that the microneedles contacts with the container.
A plurality of microneedle arrays can be held by one protective release sheet. In this case, although it is preferable that the sheet has holes as many as the microneedle arrays, a plurality of microneedle arrays may be held in one hole.
In a certain aspect of the present invention, the cutting lines are symmetrically arranged on both sides of the hole.
In addition, the cutting line basically runs between the outer edge of the protective release sheet and the hole, and it does not matter whether it runs linearly or curvilinearly. Typically one hole has two cutting lines, but the number of cutting line may be one or three. The cutting line need not run accurately toward the center of the hole, and it may be arranged in a position or direction somewhat deviated from the center of the hole. Note that it would be better to form a cutting line running from one hole to another hole in some cases.
The cutting line may be a slit which is previously cut off, but it may also be a line with perforated line which can be easily cut off.
An incision may be provided at the cutting line position on the outer edge portion of the protective release sheet. The incision facilitates cutting and removal at the cutting line position. The incision may be linear or curved.
The microneedle of the present invention comprises biosoluble materials like hyaluronic acid and collagen as raw materials, and the length of the microneedle is typically 30-1000 μm. Although the size of the substrate of the microneedle array need not particularly limited, the area of the substrate is typically 0.5-40 cm2, and the thickness of the substrate is 10-2000μ. In addition, it may have various shapes such as circular, oval, comma shape and face-shaped mask.
The protective release sheet prepared by treating one side of the polyester, polyolefin, paper or the like so as to be releasable can be used, and its shape is not limited, but a small hole which is larger than the microneedle patch and smaller than the adhesive tape should be formed in the center. Desirably, the thickness is 30 to 1,000 μm, preferably 50 to 500 μm. The thickness of less than 30 μm is inconvenient in handling, and the thickness of 1,000 μm or more may be too thick to remove the protective release sheet.
The adhesive tape of the microneedle patch can be prepared by using polyurethane, polyethylene, polyester, paper or the like as a substrate and applying an acryl- or rubber-based adhesive agent with a thickness of 5-50 μm onto a film with a thickness of 5-50 μm. Although the shape is not particularly limited, it is preferably similar to the shape of the microneedle array, such as circle, oval, comma shape and face shape.
A symbol indicating a position from which the protective release sheet is removed may be provided on one side or both sides of the cutting line of the protective release sheet. As the symbol, arrow is explicit and thus appropriate.
The microneedle patch is housed in a protective case, and then stored and transported as a microneedle patch system. In relation to the protective case, a lidded protective case having a structure that the face of the needles is fixed while kept up from the bottom for protecting the microneedles and preventing their damage should be used. As a specific method for that, the protective release sheet is preferably sandwiched from above and below by first and second case members to support the microneedle patch. Preferably, the protective case is made by thermocompression molding of a polyester sheet.
Provision of the cutting line to the protective release sheet makes the following possible for applying the microneedle patch to a skin: holding the both sides of the cutting line of the protective release sheet by both hands; bending the microneedle patch convexly outward by one hand; stripping the microneedle patch comprising the adhesive tape from the protective release sheet; and then applying the microneedle patch easily to the skin. Thereby, accidents such as contact of fingers with the microneedles and contamination of the microneedles can be prevented.
Provision of an interspace between the protective release sheet and the microneedle array can prevent the microneedle array from being torn when the protective release sheet is quickly removed. Thereby, the microneedle patch can be safely handled.
The microneedle patch can be easily handled by providing an incision or an arrow at the cutting line position on the outer edge portion of the protective release sheet. As a result, even a person unfamiliar with handling the microneedle patch can easily apply the microneedle array to the skin.
Now, the present invention will be described in detail with reference to the figures, but the present invention should not be limited to the following Examples.
The microneedle patch in the present example is shown in
Although the size of the microneedle is not limited, 30-1000 μm-long needles are provided at about 50-500 needles/cm2. Although the active ingredient thereof is hyaluronic acid, it may contain components effective in wrinkle reduction for a skin and activation for rejuvenation. In order to clarify the figures, the microneedles are omitted in the plan view of
An adhesive tape 13 is provided on the back of the microneedle array (back side of the paper face in
A protective release sheet 12 is formed in a rectangular shape with a horizontal width of 120 mm and vertical width of 70 mm and comprises a hole 14 in the center. The hole is larger than the microneedle array, and, as shown in the sectional view of
The cutting lines 15 of the protective release sheet are provided on the right and left sides of the release sheet from its outer edge toward the hole. The protective release sheet is divided into two halves by the cutting lines.
In the use of the microneedle patch, both ends of the protective release sheet 12 between which either of cutting lines runs are held, the protective release sheet is removed from the adhesive tape along the cutting line, and then the adhesive tape can be easily removed from the protective release sheet so that the microneedle array 11 can be applied to the skin through the adhesive tape 13. Subsequently, the surface of the microneedle array 11 is slightly compressed, thereby the microneedle is inserted into the stratum corneum. This insertion hardly causes sensation of pain.
The microneedle patch used in the present example is shown in
The protective release sheet 23 has cutting lines 24 in a vertical direction, and the cutting lines 24 are symmetrically arranged on both sides of the hole. In addition, a triangular incision is provided in the proximity of the outer edge of the cutting line. This incision facilitates removal of the protective release sheet. Note that the shape of the incision is not limited to the triangular shape and may be an arc shape, an oval arc shape, etc.
The cutting line 24 is provided on the upside and downside in the middle of the protective release sheet 23, so that in the use of this microneedle patch, the both ends of the protective release sheet between which either of cutting lines runs are held, and the adhesive tape with the microneedle array which was removed while the cutting line of the protective release sheet was broadened such that it was opened is brought into the site to be applied (under the eyes), thereby the patch adheres through the adhesive tape 22. Subsequently, the surface of the microneedle array 21 is slightly compressed, thereby the microneedle is inserted into the stratum corneum.
In the protective release sheet of the present example, the cutting lines of the protective release sheet are perforated lines as shown in
In addition, arrows indicating start positions for removing the protective release sheet are provided on the both side of the cutting lines. Thanks to these arrows, even a user unfamiliar with use of the microneedle patch can easily find the start position for removing the protective release sheet. Note that, the symbol indicating the start position for the removal is not limited to the arrow, and it may be a star sign or the like.
As shown in
Note that the microneedles are omitted in
As shown in
Note that the drawing of the microneedles is omitted in
As shown in
Each one of the patches can be separately applied to a skin like the microneedle patches of Examples 4 and 5. First, the microneedle patch shown in the upper part in
As shown in
As shown in
Like the microneedle patches of Examples 4-7, the microneedle patch is brought out by cutting the protective release sheet from the cutting line, and then can be separately applied to a skin.
As shown in
Like the microneedle patches of Examples 4-8, the microneedle patch is brought out by cutting the protective release sheet from the cutting line, and then can be separately applied to a skin.
The microneedle patch should be handled in a dedicated protective case for preventing contamination and damage of the needles from the fabrication to use. Preferably, the protective case is composed of the microneedle patch and the first and second case members holding the protective release sheet by sandwiching it from above and below. Additionally, the dedicated protective case holds the protective release sheet by sandwiching only the protective release sheet, and must not contact with the needle part of the microneedle patch. In addition, since the patch must be able to be brought out by merely pinching it by fingers in use, the patch is preferably held in such a way that it is kept up from the bottom of the protective case as shown in
Number | Date | Country | Kind |
---|---|---|---|
2012-156948 | Jun 2012 | JP | national |
2012-195509 | Aug 2012 | JP | national |
This application is a Divisional Application of patent application Ser. No. 14/410,300, filed on Dec. 22, 2014, which is a 371 application of Application Serial No. PCT/JP2013/067387, filed on Jun. 25, 2013, which is based on Japanese Patent Application Nos. 2012-156948 filed on Jun. 27, 2012 and 2012-195509 filed on Aug. 21, 2012, the entire contents of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
5655654 | Broskow | Aug 1997 | A |
6105579 | Levitt et al. | Aug 2000 | A |
6286511 | Levitt et al. | Sep 2001 | B1 |
6334856 | Allen et al. | Jan 2002 | B1 |
6503231 | Prausnitz et al. | Jan 2003 | B1 |
6611707 | Prausnitz et al. | Aug 2003 | B1 |
6623457 | Rosenberg | Sep 2003 | B1 |
6743211 | Prausnitz et al. | Jun 2004 | B1 |
7344499 | Prausnitz et al. | Mar 2008 | B1 |
20020000232 | Levitt et al. | Jan 2002 | A1 |
20020082543 | Park | Jun 2002 | A1 |
20020108615 | Levitt et al. | Aug 2002 | A1 |
20020138049 | Allen et al. | Sep 2002 | A1 |
20030199812 | Rosenberg | Oct 2003 | A1 |
20030208167 | Prausnitz et al. | Nov 2003 | A1 |
20050137531 | Prausnitz et al. | Jun 2005 | A1 |
20050187521 | Fleming | Aug 2005 | A1 |
20060047243 | Rosenberg | Mar 2006 | A1 |
20060051403 | Matriano et al. | Mar 2006 | A1 |
20060237338 | Nakamae | Oct 2006 | A1 |
20070083151 | Carter | Apr 2007 | A1 |
20070225676 | Prausnitz et al. | Sep 2007 | A1 |
20080009811 | Cantor | Jan 2008 | A1 |
20080108958 | Carter | May 2008 | A1 |
20080275400 | Ferguson | Nov 2008 | A1 |
20080287864 | Rosenberg | Nov 2008 | A1 |
20090131905 | Allen et al. | May 2009 | A1 |
20100256568 | Frederickson et al. | Oct 2010 | A1 |
20100312191 | Allen et al. | Dec 2010 | A1 |
20120101457 | Kato | Apr 2012 | A1 |
20130072874 | Tokumoto et al. | Mar 2013 | A1 |
Number | Date | Country |
---|---|---|
1055440 | May 1979 | CA |
2155474 | Feb 1996 | CA |
2425312 | Apr 2002 | CA |
2620943 | Mar 2007 | CA |
2425312 | Feb 2010 | CA |
2698632 | Dec 2010 | CA |
2822428 | Jun 2012 | CA |
2795995 | Dec 2012 | CA |
2847711 | Mar 2013 | CA |
2612005 | Oct 2013 | CA |
2589730 | Mar 2014 | CA |
2676255 | Jun 2016 | CA |
2676221 | Dec 2016 | CA |
2769102 | Sep 2017 | CA |
2801247 | Sep 2018 | CA |
1852845 | Oct 2006 | CN |
101208129 | Jun 2008 | CN |
201564970 | Sep 2010 | CN |
101912663 | Dec 2010 | CN |
1 086 718 | Mar 2001 | EP |
2 759 313 | Jul 2014 | EP |
2001-149485 | Jun 2001 | JP |
2001-517532 | Oct 2001 | JP |
2002-517300 | Jun 2002 | JP |
2003-238347 | Aug 2003 | JP |
2005-88921 | Apr 2005 | JP |
2006-69633 | Mar 2006 | JP |
2006-345984 | Dec 2006 | JP |
2008-512199 | Apr 2008 | JP |
2008-522731 | Jul 2008 | JP |
2008-543528 | Dec 2008 | JP |
3152532 | Aug 2009 | JP |
2010-29512 | Feb 2010 | JP |
2010029512 | Feb 2010 | JP |
2011-189093 | Sep 2011 | JP |
2011-194189 | Oct 2011 | JP |
2011-224332 | Nov 2011 | JP |
10-2007-0088775 | Aug 2007 | KR |
WO-9964580 | Dec 1999 | WO |
WO-0074763 | Dec 2000 | WO |
WO-2007002522 | Jan 2007 | WO |
WO-2007067363 | Jun 2007 | WO |
WO-2011002034 | Jan 2011 | WO |
WO-2011148994 | Dec 2011 | WO |
WO-2013042723 | Mar 2013 | WO |
Entry |
---|
English Translation of Yoshiaki JP 2010029512 (Year: 2010). |
Quan, Ying-shu et al., “The Course of Development and Manufacturing for Microneedle”, Yakuzaigaku, The Academy of Pharmaceutical Science and Technology, 2009, vol. 69, No. 4, pp. 272-276. |
International Search Report for the Application No. PCT/JP2013/067387 dated Aug. 13, 2013. |
Written Opinion of the International Searching Authority (PCT/ISA/237) for Application No. PCT/JP2013/067387 dated Aug. 13, 2013 (English Translation mailed Jan. 8, 2015). |
Notification of Reasons for Refusal for the Application No. 2014-090748 from Japan Patent Office dated Apr. 27, 2018. |
The First Office Action for the Application No. 201380031586.1 from The State Intellectual Property Office of the People's Republic of China dated Dec. 23, 2015. |
The First Office Action for the Application No. 201710747653.X from The State Intellectual Property Office of the People's Republic of China dated Oct. 14, 2019. |
Supplementary European Search Report for the Application No. EP 13 81 0059 dated Feb. 25, 2016. |
Canadian Office Action for Application No. 2,876,569 dated Nov. 23, 2018. |
Korean Office Action for Application No. 10-2014-7035927 dated Nov. 13, 2019. |
Decision of Refusal for the Application No. 2019-052074 from Japan Patent Office dated Jun. 10, 2020. |
Notification of Reasons for Refusal for the Application No. 2020-146974 from Japan Patent Office dated Jul. 6, 2021. |
Number | Date | Country | |
---|---|---|---|
20210016072 A1 | Jan 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14410300 | US | |
Child | 17065475 | US |